Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

J Clin Med. 2022 Nov 26;11(23):6983. doi: 10.3390/jcm11236983.

Abstract

Cardiac involvement of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is recognized extremely rarely. In addition, most CLL/SLL patients with heart infiltration are asymptomatic. In this review, we present the results of a literature search for English language articles concerning CLL/SLL or Richter transformation with symptomatic cardiac involvement. In total, 18 well-described cases with CLL/SLL and heart infiltration were identified. Only three patients were not diagnosed with CLL/SLL before the cardiac manifestation. In other patients, cardiac CLL/SLL was diagnosed between 5 months and 20 years from CLL/SLL diagnosis. All patients in these series had a diagnosis of secondary cardiac CLL/SLL. In addition, we identified four reported cases with Richter transformation in the heart. The treatment of patients with CLL/SLL and cardiac infiltration is variable and depends on the previous history and clinical characteristics of heart infiltration. In addition, no recommendations exist on how to treat patients with CLL/SLL and cardiac involvement.

Keywords: CLL; Richter syndrome; Richter transformation; SLL; cardiac involvement; heart; ibrutinib; rituximab; venetoclax.

Publication types

  • Review

Grants and funding

This research received no external funding.